文献速递关节外科

Synergy非骨水泥股骨柄在初次全髋关节置换术中至少15年随访的结果

The Synergy cementless femoral stem in primary total hip arthroplasty at a minimum follow-up of 15 years.
PubMed 文献 · Bone Joint J · 2017-01-01

回顾性分析112例连续初次非骨水泥全髋关节置换术(102例患者),评估Synergy非骨水泥股骨柄的长期疗效。平均年龄61岁,至少随访15年(15至17年)。以无菌性松动为终点的15年Kaplan-Meier生存率为98.9%(95%CI 96.9至100),以任何原因翻修为终点的生存率为95.7%(95%CI 91.7至99.8)。结论认为该股骨柄在15年时表现出优异的生存率和功能结果。

要点

  • 15年以无菌性松动为终点生存率98.9%(95%CI 96.9至100),以任何原因为终点95.7%(95%CI 91.7至99.8)。
  • 仅1例股骨柄因无菌性松动翻修,2例因深部感染,1例因假体周围股骨骨折。
  • Harris髋关节评分从术前平均47分(27至59)改善至末次随访89分(65至100)(p<0.001)。

核心结论

  • Synergy非骨水泥股骨柄在15年时表现出优异的生存率和功能结果。

研究设计与样本

  • 回顾性综述了102例患者(112髋)的112例连续常规初次非骨水泥全髋关节置换术,手术时平均年龄61岁(18至82),女性60例、男性42例。
  • 至少随访15年(15至17年),69例患者78髋仍在位,8例患者9髋在15年前死亡,16例患者16髋接受翻修;85例患者94髋有临床结果评分和X线片。

主要发现

  • 共4例股骨柄翻修:1例因无菌性松动,2例因深部感染,1例因假体周围股骨骨折。
  • 末次随访时西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分各组成部分均显著改善(总分p<0.001,疼痛p<0.001,僵硬p<0.001,功能p<0.001)。
  • 平均Harris髋关节评分从术前47分(27至59)改善至末次随访89分(65至100)(p<0.001)。
  • 以无菌性松动为终点的15年Kaplan-Meier生存率为98.9%(95%CI 96.9至100,15年时风险人数90),以任何原因翻修为终点的生存率为95.7%(95%CI 91.7至99.8,15年时风险人数90)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We report on the outcome of the Synergy cementless femoral stem with a minimum follow-up of 15 years (15 to 17). PATIENTS AND METHODS: A retrospective review was undertaken of a consecutive series of 112 routine primary cementless total hip arthroplasties (THAs) in 102 patients (112 hips). There were 60 female and 42 male patients with a mean age of 61 years (18 to 82) at the time of surgery. A total of 78 hips in the 69 patients remain in situ; nine hips in eight patients died before 15 years, and 16 hips in 16 patients were revised. Clinical outcome scores and radiographs were available for 94 hips in 85 patients. RESULTS: In all, four stems were revised. One stem was revised for aseptic loosening; two stems because of deep infection; and one because of periprosthetic femoral fracture. There was a significant improvement in all components of the Western Ontario and McMaster Universities Osteoarthritis Index score at the final follow-up (total: p < 0.001, pain: p < 0.001, stiffness: p < 0.001, function: p < 0.001). The mean Harris Hip Scores improved from 47 points (27 to 59) pre-operatively to 89 points (65 to 100) at the latest follow-up (p < 0.001). Kaplan-Meier survivorship, with stem revision for aseptic loosening as the endpoint, was 98.9% at 15 years (95% confidence interval (CI) 96.9 to 100, number at risk at 15 years: 90) and with stem revision for any reason was 95.7% (95% CI 91.7 to 99.8, number at risk at 15 years: 90). CONCLUSION: The Synergy cementless femoral stem demonstrates excellent survivorship and functional outcomes at 15 years. Cite this article: Bone Joint J 2017;99-B:29-36.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. De Martino I, De Santis V, D'Apolito R, et al. The Synergy cementless femoral stem in primary total hip arthroplasty at a minimum follow-up of 15 years. Bone Joint J. 2017. PMID: 28053254. doi:10.1302/0301-620X.99B1.BJJ-2016-0231.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。